10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Activism affects virtually everyone now—even those who may never have to deal with an activist - I...
Read More >
On January 14, 2020, the Brazilian Ministry of Economy issued an ordinance fixing the 2020 maximum p...
Read More >
Seyfarth Synopsis: The New York State Department of Labor has issued guidance concerning the recentl...
Read More >
In a unanimous decision, the U.S. Supreme Court ruled that Title VII’s charge-filing precondition t...
Read More >
As of July 15, 2019, the Equal Employment Opportunity Commission (EEOC) is equipped to accept 2017 a...
Read More >
We conclude our blog series on best practices in administering benefit claims with the three C’s: b...
Read More >